ID-Migraine is a sensitive tool for screening migraine among patients with multiple sclerosis

Authors

  • Marcos Vinícius de Queiroz
  • Washington Luiz G. Medeiros Jr
  • Audred C. Biondo Eboni
  • Eduardo A. Guimaraes Nogueira
  • Marcus Vinicius M. Gonçalves
  • Nise Alessandra C. Sousa
  • Yara Dadalti Fragoso

DOI:

https://doi.org/10.48208/HeadacheMed.2019.2

Keywords:

Migraine, Headache, Multiple Sclerosis, Interferon

Abstract

Introduction: Migraine and multiple sclerosis (MS) have been described as comorbidities. While other types of headaches can be seen in patients with MS, it is migraine that usually adds to the burden of patients suffering from an already disabling and chronic neurological disease. Migraine is more prevalent in patients with MS than in the general population, and can be worsened by certain treatments that are used to control MS. ID-migraine is a tool to screen migraine in a population. It consists of only three self-reported questions, and shows good sensitivity, specificity and reliability. The aim of the present study was to assess the role of ID-migraine as a potential tool for screening migraine in patients with MS. Method: Patients diagnosed with MS for at least one year were invited to answer ID-migraine. Demographic data and information on MS therapy were obtained at the same time. Results: Sixty-two patients participated in the study. There were 16 men and 46 women, of average age 35 years. Migraine was identified in 51.5% of them and 18% reported having the characteristics of chronic migraine. ID-migraine showed 93% sensitivity and specificity for migraine in this population. The medication most frequently associated with worsening of previous migraine was interferon beta 1-a (27.4% of the cases). Conclusion: ID-migraine was shown to be a potential tool for identifying migraine in patients with MS. However, the high prevalence of migraine in this population may have constituted a selection bias, since most
patients without headache may not have felt inclined to participate in this voluntary investigation. The results from this pilot study will be expanded and investigated in more detail in a large national study.

Downloads

Download data is not yet available.

Author Biographies

Marcos Vinícius de Queiroz

Department of Neurology and Programa de Pós-Graduação em Saúde e Ambiente, Universidade Metropolitana de Santos, Santos, SP, Brazil

Washington Luiz G. Medeiros Jr

Department of Neurology, Universidade da Região de Joinville, Joinville, SC, Brazil

Audred C. Biondo Eboni

Department of Neurology, Universidade da Região de Joinville, Joinville, SC, Brazil

Eduardo A. Guimaraes Nogueira

Department of Neurology and Programa de Pós-Graduação em Saúde e Ambiente, Universidade Metropolitana de Santos, Santos, SP, Brazil

Marcus Vinicius M. Gonçalves

Department of Neurology, Universidade da Região de Joinville, Joinville, SC, Brazil

Nise Alessandra C. Sousa

Department of Neurology, University Hospital Getulio Vargas, Manaus, AM, Brazil

Yara Dadalti Fragoso

Department of Neurology and Programa de Pós-Graduação em Saúde e Ambiente, Universidade Metropolitana de Santos, Santos, SP, Brazil

Downloads

Published

2019-03-31

How to Cite

1.
Queiroz MV de, Medeiros Jr WLG, Eboni ACB, Nogueira EAG, Gonçalves MVM, Sousa NAC, Fragoso YD. ID-Migraine is a sensitive tool for screening migraine among patients with multiple sclerosis. Headache Med [Internet]. 2019 Mar. 31 [cited 2024 Mar. 2];10(1):2-4. Available from: https://headachemedicine.com.br/index.php/hm/article/view/58

Issue

Section

Original

Most read articles by the same author(s)